Rankings

GLP-1 coverage in Mississippi

Notable for its obesity prevalence rather than its coverage rules. What that means, the indications that are still mandatory, and what it costs if you pay cash.

Updated 2026-09-18

DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.

Mississippi is one of only two states with adult obesity prevalence above 40%.

CDC’s 2024 data put Mississippi at 40.4%, second only to West Virginia. Mississippi is also one of the states KFF lists as covering GLP-1s for obesity under Medicaid — making it one of the few places where the highest clinical need and an available public route actually coincide. Everything below is sourced — we are not going to tell you what a Mississippi clinic charges, because every provider we track is 50-state telehealth and prices the same wherever you live. What actually differs by state is coverage, and that is what this page is about.

Why Mississippi is different

Mississippi is the other state above 40% adult obesity prevalence, at 40.4%. Together with West Virginia it represents the sharpest version of the national problem: highest clinical need, least individual capacity to pay, and a Medicaid programme where obesity coverage is optional rather than required.

Medicaid and GLP-1s in Mississippi

Coverage for obesity is optional for states — the national picture is on our coverage index. Here is where Mississippi sits.

	Mississippi
Status	Notable for its obesity prevalence rather than its coverage rules
Region	South — regional adult obesity prevalence 34.5%
State adult obesity prevalence	40.4% (CDC, 2024)
Board of pharmacy	Mississippi Board of Pharmacy

If you are on Medicaid in Mississippi

What to do in Mississippi: Pursue the mandatory indications first — in a state with this prevalence, the proportion of adults who also have a qualifying diagnosis is substantial.

Coverage for type 2 diabetes, cardiovascular disease and sleep apnea is mandatory everywhere, so a refusal framed around weight loss is not the end of it — and on Medicare, the $50 programme starts 1 July 2026 regardless of which state you are in.

Paying cash in Mississippi

Providers are licensed across all 50 states and charge the same here as anywhere, so there is no local price to hunt for — the cheapest verified all-in rates are Ozari Health at $86 for semaglutide and Trimi at $125 for tirzepatide. Full tables in the cheapest tirzepatide. If you buy compounded, check the pharmacy licence with the Mississippi Board of Pharmacy, or with the board in whichever state that pharmacy actually operates from — frequently not Mississippi.

Mississippi: common questions

Is Mississippi's rate still rising?

CDC's 2024 figure is 40.4%, one of only two states above 40%. The agency publishes the maps annually, so the current position is worth checking directly rather than relying on a figure that may be a year old.

Does high prevalence make coverage more likely?

Apparently not. Coverage decisions track state budgets rather than prevalence, which is why two of the highest-prevalence states in the country have among the most limited access.

Sources: KFF, “Medicaid Coverage of and Spending on GLP-1s”, 16 January 2026; CDC Adult Obesity Prevalence Maps, 2024 data, published 3 December 2025. Verified 2026-09-18. Coverage positions change mid-year — confirm yours with your plan. Not medical, legal or benefits advice.